MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Relationship between neuropsychological functioning and subjective measures of sleep quality in Parkinson Disease

    E. Montanaro, M. Zibetti, F. Dematteis, L. Lopiano (Torino, Italy)

    Objective: To analyze the relationship between subjectively reported sleep alterations and cognitive functions in a large series of advanced Parkinson Disease (PD) patients evaluated with…
  • 2017 International Congress

    Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease

    E. De Pablo-Fernandez, J. Holton, T. Warner (London, United Kingdom)

    Objective: Assessment of severity of α-synuclein pathology in the circadian system in patients with Parkinson’s disease (PD). Background: Circadian system is responsible for the 24-hour…
  • 2017 International Congress

    Parkinson’s disease phenotype across different ethnic groups: Comparison of non-motor symptoms in patients living in the United Kingdom and Mexico

    A. Sauerbier, M. Rodriguez Violante, A. Cervantes Arriaga, A. Rizos, D. Trivedi, P. Martinez-Martin, M. Parry, M. Rosa-Grilo, R. Brown, K. Ray Chaudhuri (London, United Kingdom)

    Objective: The aim is to compare and contrast clinical profiles between UK-White Caucasian (UK-WC), UK-Asian, UK-Black African Caribbean (UK-BAC) and Mexican people with Parkinson's disease…
  • 2017 International Congress

    Lower urinary tract symptoms in patients with Parkinson’s Disease: findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, Y. Sidhom, K. Achour, I. Kacem, A. Gargouri, R. Gouider (Manouba, Tunisia)

    Objective: To assess lower urinary tract symptoms (LUTS) in patients with Parkinson’s disease (PD) and to investigate their impact on the quality of Life (QoL).…
  • 2017 International Congress

    A new aroma in the new world

    H. Fajardo, A. Medina, P. Gomez, r. Medina (tegucigalpa, Honduras)

    Objective: Investigate if olfactory impairment in PD patients  are related with other non motor symptoms Background: Non motor symptoms (NMS) can precede Parkinson's Disease (PD)…
  • 2017 International Congress

    Sleep quality in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel infusion

    O. De Fabregues, A. Ferré, O. Romero, J. Dot, M. Abu-Suboh, M. Quintana, J.R. Armengol, J. Alvarez-Sabin (Barcelona, Spain)

    Objective: To describe the effects of levodopa/carbidopa intestinal gel (LCIG) infusion on sleep quality in patients with advanced Parkinson's disease (PD).  Background: Worsening of sleep…
  • 2017 International Congress

    The impact of divided attention in dual task conditions on drooling in Parkinson’s Disease (PD): a pilot study

    H. Reynolds, N. Miller, R. Walker (Gateshead, United Kingdom)

    Objective: To investigate whether frequency of saliva swallows reduced, and drooling severity and frequency increased, when people with PD engaged in a distracting cognitively demanding…
  • 2017 International Congress

    Deep Brain Stimulation and Olfactory Function in Parkinson’s Disease

    O. Saatci, B. Polat, N. Helvaci Yilmaz, T. Zirh (Istanbul, Turkey)

    Objective: To evaluate the olfactory functions in the preoperative and postoperative period in Parkinson's Disease (PD) patients who underwent deep brain stimulation (DBS) of bilateral subthalamic nucleus (STN)…
  • 2017 International Congress

    Probiotic correction of intestinal dysbiosis in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To reveal the effect of probiotic on the content and condition of intestinal microbiota in Parkinson's disease (PD). Background: Constipation is an important non-motor…
  • 2017 International Congress

    Parkinson’s Disease from the Patient Perspective

    L. Mischley, G. Canada, R. Lau (Kenmore, WA, USA)

    Objective: The purpose of this study was to describe the constellation of parkinsonian symptoms, as experienced by the patient. Background: For 200 years, the cardinal…
  • « Previous Page
  • 1
  • …
  • 1384
  • 1385
  • 1386
  • 1387
  • 1388
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley